Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2021-001885-40Phase 4Active
Phase 4 trial of amoxicillin in edentulism and None (2 arms), sponsored by Complutense University of Madrid. Primary endpoint: Patient-reported outcome measures. Started Dec 2024; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2021-001885-40.